ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 047,92
-1,85%
Dow Jones
42 520,99
-1,55%
DAX
22 326,81
-3,51%
Brent Oil
71,035
-0,51%
Bitcoin
87 220,03
1,32%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Crism Therapeutics Corporation (CRTX)

  7. Crism Therapeutics Corporation (CRTX) Actualités

CRTX

Crism Therapeutics (CRTX)

Crism Therapeutics Corporation
De:
Trier par:
 Showing the most relevant articles for your search:LSE:CRTX
DateHeureSourceTitreSymboleSociété
20/12/202408h00RNS Regulatory NewsCRISM Therapeutics Corporation Appointment of Specialist Clinical CROLSE:CRTXCrism Therapeutics Corporation
19/12/202409h32Alliance NewsAlliance NewsIN BRIEF: CRISM Therapeutics gets European patent for tumour therapyLSE:CRTXCrism Therapeutics Corporation
18/12/202408h00RNS Regulatory NewsCRISM Therapeutics Corporation European Patent GrantLSE:CRTXCrism Therapeutics Corporation
19/09/202408h00RNS Regulatory NewsCRISM Therapeutics Corporation Interim ResultsLSE:CRTXCrism Therapeutics Corporation
09/09/202408h00RNS Regulatory NewsCRISM Therapeutics Corporation Notice of Interim Results & IMC PresentationLSE:CRTXCrism Therapeutics Corporation
03/09/202408h00RNS Non-RegulatoryCRISM Therapeutics Corporation Delivery Method Validated in Peer Reviewed JournalLSE:CRTXCrism Therapeutics Corporation
02/09/202408h00RNS Regulatory NewsCRISM Therapeutics Corporation Innovation Passport AwardLSE:CRTXCrism Therapeutics Corporation
30/07/202408h00RNS Regulatory NewsCrism Therapeutics Corporation CRISM Signs Service Agreement ContractLSE:CRTXCrism Therapeutics Corporation
03/07/202420h03Alliance NewsAlliance NewsIN BRIEF: Crism flags contract talks, reacts to share price surgeLSE:CRTXCrism Therapeutics Corporation
03/07/202417h18RNS Regulatory NewsCrism Therapeutics Corporation Response to Movement in Share PriceLSE:CRTXCrism Therapeutics Corporation
03/06/202416h25RNS Regulatory NewsCrism Therapeutics Corporation Director DealingLSE:CRTXCrism Therapeutics Corporation
31/05/202422h58Alliance NewsAlliance NewsIN BRIEF: Crism has first day of trade on AIM after name change, buyLSE:CRTXCrism Therapeutics Corporation
31/05/202408h00RNS Regulatory NewsCrism Therapeutics Corporation Admission to Trading and First Day of DealingsLSE:CRTXCrism Therapeutics Corporation
18/12/200919h45PR Newswire (US)Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010NASDAQ:CRTX
20/11/200921h40PR Newswire (US)Cornerstone Therapeutics Provides a Response to FDA Warning Letter on DeconsalNASDAQ:CRTX
16/11/200914h00PR Newswire (US)Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare ConferenceNASDAQ:CRTX
13/11/200914h00PR Newswire (US)Cornerstone Therapeutics Appoints General CounselNASDAQ:CRTX
04/11/200913h00PR Newswire (US)Cornerstone Therapeutics Reports Third Quarter 2009 Financial ResultsNASDAQ:CRTX
21/10/200914h00PR Newswire (US)Cornerstone Therapeutics to Host Third Quarter 2009 Conference CallNASDAQ:CRTX
03/09/200914h01PR Newswire (US)Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)NASDAQ:CRTX
03/09/200914h00PR Newswire (US)Cornerstone Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:CRTX
20/07/200914h00PR Newswire (US)Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business JournalNASDAQ:CRTX
16/07/200901h04PR Newswire (US)Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive ProductNASDAQ:CRTX
08/07/200922h15PR Newswire (US)Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect tNASDAQ:CRTX
12/06/200922h35Dow Jones NewsUPDATE:FDA Updates Singulair Label For Neuropsychiatric EventsNASDAQ:CRTXCornerstone Therapeutics Inc.
12/06/200921h28Dow Jones NewsFDA: Updates Singulair Label For Neuropsychiatric EventsNASDAQ:CRTXCornerstone Therapeutics Inc.
19/05/200922h01PR Newswire (US)Cornerstone Therapeutics Announces Management ChangeNASDAQ:CRTX
07/05/200913h01PR Newswire (US)Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpANASDAQ:CRTX
07/05/200913h00PR Newswire (US)Cornerstone Therapeutics Reports First Quarter 2009 Financial ResultsNASDAQ:CRTX
27/04/200914h00PR Newswire (US)Cornerstone Therapeutics to Host First Quarter 2009 Conference CallNASDAQ:CRTX
 Showing the most relevant articles for your search:LSE:CRTX

Dernières Valeurs Consultées

BIT
P1NA05
BNP Paribas Issuance
BIT
UC5F08
Unicredit Bank
BIT
P1TJY2
BNP Paribas Issuance
BIT
UC3U53
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces